Technology | PET-CT | June 21, 2018

FDA Clears New Imaging Functionalities for Biograph mCT PET/CT Systems

New features designed to advance clinical capabilities for entire Biograph mCT family of PET/CT systems

FDA Clears New Imaging Functionalities for Biograph mCT PET/CT Systems

June 21, 2018 — Siemens Healthineers will announce U.S. Food and Drug Administration (FDA) clearance of four new system features for the Biograph mCT family of positron emission tomography/computed tomography (PET/CT) systems at the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). These features, three of which are also available on the Biograph Vision PET/CT scanner, bring advanced clinical capabilities to healthcare providers, enabling them to expand precision medicine and transform the delivery of patient care.

The QualityGuard¹ feature self-calibrates the PET detector by tapping natural background radiation from the lutetium oxyorthosilicate (LSO) detectors to run daily and weekly quality control (QC) procedures during off-hours. This saves up to 30 minutes of staff time per day, according to Siemens. Self-calibration eliminates use of a radioactive source for daily and weekly manual calibration, thereby reducing the technologist’s radiation exposure in addition to eliminating the need to lift the radioactive source, which can weigh 25 to 30 lbs.

A second feature, FlowMotion Multiparametric PET Suite, is fully automated and delivers whole-body parametric PET images based on the Patlak reference tissue model. In a single examination and without the need for arterial blood sampling, FlowMotion Multiparametric PET Suite provides images of metabolic rate and distribution volume in addition to standard uptake value (SUV) images. FlowMotion Multiparametric PET Suite reduces the variability of quantitative measurements due to differences in uptake time, patient body size and blood glucose levels. This leads to better characterization of tracer uptake compared to SUV alone.

The OncoFreeze feature provides images that are virtually free of respiratory motion in the same time as a standard whole-body scan. Traditionally, respiratory gated images use only select information from a portion of the patient’s respiratory cycle; the remaining data from the PET/CT scan is discarded. OncoFreeze utilizes 100 percent of acquired information from the respiratory cycle and reduces acquisition time.

Finally, CardioFreeze corrects for respiratory and cardiac motion associated with cardiac PET/CT image acquisitions and can obtain the respiratory waveform just by analyzing PET data. Each cardiac gate is reconstructed with 100 percent of the data acquired. This eliminates variability from cardiac and respiratory motion, and improving visualization of myocardial tracer distribution, wall thickness and defect definition.

For more information: www.usa.healthcare.siemens.com

 

Reference

1. QualityGuard is currently under development on Biograph Vision and is not available for sale in the U.S. or any other country.

Related Content

Researchers Trace Parkinson’s Damage in the Heart
News | PET Imaging | July 17, 2018
A new way to examine stress and inflammation in the heart will help Parkinson’s researchers test new therapies and...
Siemens Healthineers Announces FDA Clearance of syngo.via VB30 Molecular Imaging Software
Technology | Nuclear Imaging | July 16, 2018
At the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23-26 in Philadelphia...
Siemens Healthineers Launches Acuson Sequoia Ultrasound
Technology | Ultrasound Imaging | July 12, 2018
July 12, 2018 — Siemens Healthineers recently announced the launch of its new ultrasound system, the Acuson Sequoia.
Invision Diagnostics Installs VolparaEnterprise Software to Enhance Mammography Image Quality
News | Mammography | July 11, 2018
Invision Diagnostics, a provider of mobile mammography services across North and South Carolina, announced that it is...
Hologic Announces Availability of Viera Portable Breast Ultrasound System
Technology | Ultrasound Women's Health | July 11, 2018
Hologic’s new Viera portable breast ultrasound system is now available for purchase in the United States and Europe....
Guerbet, IBM Watson Health Partner on Artificial Intelligence for Liver Imaging
News | Clinical Decision Support | July 10, 2018
Guerbet announced it has signed an exclusive joint development agreement with IBM Watson Health to develop an...
SNMMI Image of the Year Highlights Theranostic Approach for Advanced Prostate Cancer

IMAGE OF THE YEAR: PSMA PET before and after lutetium-177 PSMA617 theranostics in 8 patients with metastatic prostate cancer who exhausted standard therapeutic options.

68Ga-PSMA11 PET maximum intensity projection (MIP) images at baseline and 3 months after 177Lu-PSMA617 in 8 patients with PSA decline ≥ 98 percent in a prospective phase II study. Any disease with SUV over 3 is in red. Credit: Michael Hofman, John Violet, Shahneen Sandhu, Justin Ferdinandus, Amir Iravani, Grace Kong, Aravind Ravi Kumar, Tim Akhurst, Sue Ping Thang, Price Jackson, Mark Scalzo, Scott Williams and Rodney Hicks, Peter MacCallum Cancer Centre, Melbourne, Australia.

News | PET Imaging | June 29, 2018
In the battle against metastatic castrate-resistant prostate cancer, studies have demonstrated a high response rate to...
MILabs Introduces Futuristic PET Capabilities on New VECTor6 System
Technology | PET Imaging | June 28, 2018
At the 2018 Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, June 23-26, in Philadelphia,...
Konica Minolta Launches SonImage MX1 Portable Ultrasound System
Technology | Ultrasound Imaging | June 28, 2018
Konica Minolta Healthcare Americas Inc. introduced the SonImage MX1 portable ultrasound system, optimized for...
Overlay Init